Brief: Mabpharm Says Unit Entered Into An Exclusive Promotion Service Agreement With Kexing Biopharm
31/03/2022 14:40
March 31 (Reuters) - Mabpharm Ltd 2181.HK :
* UNIT ENTERED INTO AN EXCLUSIVE PROMOTION SERVICE AGREEMENT
WITH
KEXING BIOPHARM
* UNDER AGREEMENT, UNIT GRANTED AN EXCLUSIVE LICENCE TO
PROMOTE
CMAB008 IN MAINLAND CHIN TO KEXING BIOPHARM
Further company coverage: 2181.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mabpharm
See all newsBrief: Mabpharm Says NMPA Approves CMAB807X (Denosumab Injection) NDA
Brief: Mabpharm Says NMPA Approves Cmab807 (Denosumab Injection) NDA
Brief: Mabpharm FY Profit And Total Comprehensive Income Attributable Rmb57.1 Million
Brief: Mabpharm Says Approval From Drug Regulatory Authority Of Pakistan On Registration Of Core Product,CMAB008
Brief: Mabpharm Says Approval From Indonesian National Agency Of Drug And Food Control Of CMAB008